Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy helps diagnose different scalp conditions by showing unique signs for each disorder.

Mnemonics help improve memory in dermatology by up to 50%.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

MS patients often have skin issues, so regular skin checks are important.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

The document concludes that diagnosing and managing plaque psoriasis, particularly in sensitive areas, is challenging and requires careful differentiation from similar skin conditions.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Custom skincare can be made based on genes, fewer cats in Lublin have FeLV/FIV than national average, and studies also looked at small water bodies, river pollution, guppy growth, toxins in biochars, palm oil issues, and pumpkin seed oil for hair strength.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Cosmetics can help with mild skin problems and daily care but must be used carefully to avoid skin irritation.

Elderly people often have skin issues like wrinkles, dryness, and benign tumors, needing special dermatology care.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.